Cleared Traditional

K912615 - ROCHE COBAS ARGOS 5 DIFF

K912615 is an FDA 510(k) clearance for ROCHE COBAS ARGOS 5 DIFF, manufactured by Roche Diagnostic Systems, Inc.. The device is a Class 2 Hematology device with product code GZI cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K912615 · Roche Diagnostic Systems, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1991
Decision
106d
Days
Class 2
Risk

K912615 is an FDA 510(k) clearance for the ROCHE COBAS ARGOS 5 DIFF. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Roche Diagnostic Systems, Inc. (Montclair, US). The FDA issued a Cleared decision on September 27, 1991 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 882.5810 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostic Systems, Inc. devices

FDA 510(k) Submission Details - K912615

510(k) Number K912615 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 1991
Decision Date September 27, 1991
Days to Decision 106 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 113d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 35
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K912615.
RT600
K103366 · Restorative Therapies, Inc. · Apr 2011
EXTERNAL FUNCTIONAL NEUROMUSCULAR STIMULATOR
K974514 · Neuromotion, Inc. · Feb 1998
FORTE ES
K940759 · Chattanooga Group, Inc. · Mar 1995
SELECT NEUROMUSCULAR STIMULATORS
K903434 · Medtronic Vascular · Aug 1991
FES ORTHOSIS MODEL NO. 2000
K800380 · Empi · Mar 1980